ADVERTISEMENT
t

Controversial treatment for dwarfism meets clinical trial goals. Is FDA approval coming?

A treatment for the most common cause of dwarfism met its goal of increasing height in a pivotal study, the ...

We Noticed You Have An Ad Blocker On.

Can you help fund the GLP? We're a nonprofit, so it's tax-deductible.

glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.